These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19836041)

  • 1. [Treatment of autoimmune myasthenia].
    Pénisson-Besnier I
    Rev Neurol (Paris); 2010 Apr; 166(4):400-5. PubMed ID: 19836041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autoimmune myasthenia gravis.
    Richman DP; Agius MA
    Neurology; 2003 Dec; 61(12):1652-61. PubMed ID: 14694025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis.
    Tindall RS
    Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis.
    Silvestri NJ; Wolfe GI
    Semin Neurol; 2012 Jul; 32(3):215-26. PubMed ID: 23117946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of myasthenia gravis: an audit.
    Simpson JA; Thomaides T
    Q J Med; 1987 Aug; 64(244):693-704. PubMed ID: 3328214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Actual aspects of myasthenia gravis treatment].
    Czapliński A; Radziwiłł AJ; Steck AJ
    Pol Merkur Lekarski; 2003 Mar; 14(81):256-60. PubMed ID: 12914109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune diseases against cell surface receptors: myasthenia gravis, a prototype anti-receptor disease.
    De Baets MH
    Neth J Med; 1994 Dec; 45(6):294-301. PubMed ID: 7838246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapies in myasthenia gravis.
    Sanders DB; Evoli A
    Autoimmunity; 2010 Aug; 43(5-6):428-35. PubMed ID: 20166870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopharmacological treatment in myasthenia gravis.
    Nyberg-Hansen R; Gjerstad L
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):201-10. PubMed ID: 3289206
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future therapies for myasthenia gravis.
    Yi Q; Lefvert AK
    Drugs Aging; 1997 Aug; 11(2):132-9. PubMed ID: 9259176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenic crisis: guidelines for prevention and treatment.
    Jani-Acsadi A; Lisak RP
    J Neurol Sci; 2007 Oct; 261(1-2):127-33. PubMed ID: 17544450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essentials in the management of myasthenia gravis.
    Galdi AP
    Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acquired autoimmune myasthenia gravis: a topic review.
    Verma P; Oger J
    Can J Neurol Sci; 1992 Aug; 19(3):360-75. PubMed ID: 1393847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular myasthenia: diagnosis and treatment].
    Stojkovic T; Béhin A
    Rev Neurol (Paris); 2010 Dec; 166(12):987-97. PubMed ID: 21075410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of intravenous immunoglobulins to the treatment of myasthenia].
    Gajdos P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S30-4. PubMed ID: 10896986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis.
    Plauché WC
    Clin Obstet Gynecol; 1983 Sep; 26(3):592-604. PubMed ID: 6352124
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myasthenia gravis. Indications, aims and methods of intensive therapy].
    Braschi A; Scherini A; Carbonera D; Mapelli A; Bellinzona G; Bobbio Pallavicini F; Dionigi R; Gasperi A
    Minerva Anestesiol; 1979 Nov; 45(11):871-81. PubMed ID: 548812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.